COMMON EQUITY (Tables)

3 Months Ended

Mar. 31, 2024

Equity [Abstract]

Schedule of stock-based compensation awards granted

During the three months ended March 31, 2024, the Compensation Committee of our Board of Directors awarded the following stock-based compensation to our directors, officers, and certain other key employees:

Award Type	Number of Awards
Stock options (1)	283,869
Restricted shares (2)	105,778
Performance units	196,256

(1)Stock options awarded had a weighted-average exercise price of $85.05 and a weighted-average grant date fair value of $16.20 per option.

(2)Restricted shares awarded had a weighted-average grant date fair value of $85.05 per share.

Schedule of Common Stock Outstanding Roll Forward

We had the following changes to our outstanding common stock during the three months ended March 31, 2024:

Common stock shares outstanding at beginning of period	315,434,531
Shares issued:
Stock-based compensation	142,178
401(k)	124,300
Stock investment plan	121,578
Common stock shares outstanding at end of period	315,822,587